ezogabine has been researched along with bumetanide in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (bumetanide) | Trials (bumetanide) | Recent Studies (post-2010) (bumetanide) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 2,033 | 150 | 354 |
| Protein | Taxonomy | ezogabine (IC50) | bumetanide (IC50) |
|---|---|---|---|
| Solute carrier family 12 member 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auvin, S; Kwon, YS; Mazarati, A; Pineda, E; Sankar, R; Shin, D | 1 |
1 other study(ies) available for ezogabine and bumetanide
| Article | Year |
|---|---|
Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.
Topics: Age Factors; Animals; Animals, Newborn; Anticonvulsants; Bumetanide; Carbamates; Disease Models, Animal; Fructose; Hippocampus; Kindling, Neurologic; Phenylenediamines; Rats; Topiramate | 2010 |